The trial will focus on evaluating the Kiva System against Medtronic’s Kyphon Balloon Kyphoplasty. The trial enrolled 300 patients and is being conducted to support a subsequent 510(k) filing for market clearance from the U.S. Food and Drug Administration.
More Articles on Orthopedic Devices:
Medtronic Receives 510(k) Approval for Orthopedic Sealer
10 Milestones for Spine Implants & Device Companies
Zimmer Net Sales Reaches $1.1B, Down 1.1%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
